Inconsistent with previous studies, the Multi-Ethnic Study of Atherosclerosis (MESA) recently found that FGF21 levels were not associated with incident cardiovascular disease after multiple adjustments (Ong et al., 2019); however, this study enrolled only patients without cardiovascular disease. Here, FGF21 is linked to cardiovascular disorder.